TherapeuticsMD
TXMD
#10102
Rank
NZ$41.51 M
Marketcap
NZ$3.59
Share price
-6.09%
Change (1 day)
84.96%
Change (1 year)

Market capitalization of TherapeuticsMD (TXMD)

Market cap: NZ$41.51 Million

As of February 2026 TherapeuticsMD has a market cap of NZ$41.51 Million. This makes TherapeuticsMD the world's 10102th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of TherapeuticsMD from 2003 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$41.51 M19.37%
2025NZ$34.77 M56.02%
2024NZ$22.28 M-40.76%
2023NZ$37.62 M-54.86%
2022NZ$83.35 M-62.31%
2021NZ$0.22 B-56.01%
2020NZ$0.50 B-48.41%
2019NZ$0.97 B-28.66%
2018NZ$1.36 B-25.8%
2017NZ$1.84 B12.41%
2016NZ$1.63 B-39.26%
2015NZ$2.69 B204.09%
2014NZ$0.88 B-3.55%
2013NZ$0.91 B144.44%
2012NZ$0.37 B140.93%
2011NZ$0.15 B23333.18%
2010NZ$0.66 M-97.64%
2009NZ$28.26 M973.99%
2008NZ$2.63 M286.17%
2007NZ$0.68 M-56.45%
2006NZ$1.56 M29.36%
2005NZ$1.2 M52.86%
2004NZ$0.79 M-17.51%
2003NZ$0.95 M

End of Day market cap according to different sources

On Jan 31st, 2026 the market cap of TherapeuticsMD was reported to be:

NZ$41.51 Million
by Nasdaq info icon info icon
NZ$41.51 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
NZ$249.60 B 601,205.40%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$654.43 B 1,576,438.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Agile Therapeutics
AGRX
NZ$17.31 M-58.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
NZ$40.35 B 97,124.38%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lannett Company
LCI
NZ$12.25 M-70.48%๐Ÿ‡บ๐Ÿ‡ธ USA